Ji Wan

Title: Innovations by Inventor Ji Wan

Introduction

Ji Wan is a prominent inventor based in Shenzhen, China. He has made significant contributions to the field of biomedical technology, particularly in the area of tumor neoantigen research. With a total of two patents to his name, Ji Wan is recognized for his innovative methods that enhance the understanding and detection of tumor immunogenicity.

Latest Patents

Ji Wan's latest patents include a "Method and system for calculating tumor neoantigen burden" and a "Method and platform for detecting immunogenicity of tumor neoantigen." The first patent provides a comprehensive method for calculating tumor neoantigen burden (TNB) by processing normal and tumor samples, detecting somatic mutations, and predicting binding affinities between neopeptide sequences and human leukocyte antigen (HLA) genotypes. The second patent outlines a method and platform for detecting the immunogenicity of tumor neoantigens, which involves culturing human peripheral blood monocytes and conducting enzyme-linked immunospot (ELISPOT) assays. This method is noted for its short detection period, high convenience, and low cost.

Career Highlights

Ji Wan has worked with notable companies in the biomedical field, including Neocura Biomedical Technology Co., Ltd and Beijing Neocurna Biotechnology Corporation. His work in these organizations has contributed to advancements in cancer research and immunotherapy.

Collaborations

Some of Ji Wan's coworkers include Youdong Pan and Qi Song. Their collaborative efforts have furthered the research and development of innovative solutions in the biomedical sector.

Conclusion

Ji Wan's contributions to the field of tumor neoantigen research through his patents and career highlights demonstrate his commitment to advancing biomedical technology. His innovative methods are paving the way for improved cancer diagnostics and treatments.